Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BioFoam is a medical technology company specializing in the development of advanced hemostatic solutions for surgical and emergency applications. The company's core technology is a proprietary, injectable foam that rapidly expands to fill wound cavities and control severe bleeding in non-compressible areas of the body. This innovative approach provides a critical tool for surgeons and first responders to manage life-threatening hemorrhages where traditional methods like pressure or tourniquets are ineffective. BioFoam's products are designed to be biocompatible and easily removable, facilitating subsequent definitive surgical repair.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BioFoam.